Key result
Surgical removal of a 35 mm Amplatzer occluder and septal reconstruction successfully resolved a residual shunt and thrombus 21 years after ASD closure, with no adverse events at 5-6 months.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Case report reveals a stroke related to long-term ASD device complications, indicating need for lifelong monitoring.
Background Very late complications of percutaneous closure of atrial septal defects (ASD) are rare and poorly described in literature. Case Summary A 53-year-old woman presented with acute-onset diplopia and aphasia. She was diagnosed with ischemic stroke and underwent thrombolysis. Brain MRI showed bilateral thalamic infarcts. Workup revealed a residual shunt through a previously implanted Amplatzer occluder placed 21 years earlier for a large, fenestrated ASD. Transesophageal echocardiography demonstrated device-associated thrombus and significant right-to-left shunting on Valsalva. Percutaneous reclosure was unsuccessful due to a serpiginous intracardiac tract. Surgical removal of the device, septal reconstruction, and tricuspid valvuloplasty were performed via right minithoracotomy. Postoperative recovery was uneventful, and the patient remained asymptomatic at six-month follow-up. Conclusion Very late device-related complications, even decades after percutaneous ASD closure may occur. Life-long follow-up in patients with complex ASD is needed. Surgical closure may be considered in anatomically challenging cases to reduce long-term risk.
No takes yet. Share an insight, caveat, or question.
Levra et al. (2026) conducted a case report in Very late residual shunt, device-associated thrombus, and paradoxical ischemic stroke following percutaneous closure of a large fenestrated atrial septal defect (n=1). Surgical removal of Amplatzer septal occluder, interatrial septal reconstruction, and De Vega tricuspid valvuloplasty (following unsuccessful percutaneous reclosure) was evaluated on Resolution of residual shunt and postoperative clinical recovery without adverse events. Surgical removal of a 35 mm Amplatzer occluder and septal reconstruction successfully resolved a residual shunt and thrombus 21 years after ASD closure, with no adverse events at 5-6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: